[Childhood obesity. Recommendations of the Nutrition Committee of the Spanish Association of Pediatrics. Part II. Diagnosis. Comorbidities. Treatment].
The present article reviews the diagnostic criteria for pediatric obesity and its comorbidities. Treatment is also reviewed, including promotion of physical activity, and dietetic, pharmacologic and surgical treatment.
Dalmau Serra
J
J
Unidad de Nutrición y Metabolopatías, Hospital Infantil La Fe, Valencia, España.
Alonso Franch
M
M
Gómez López
L
L
Martínez Costa
C
C
Sierra Salinas
C
C
D019440:Anti-Obesity Agents / Q000627:therapeutic use; D001067:Appetite Depressants / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000453:epidemiology*; D002648:Child; D003131:Combined Modality Therapy; D003503:Cyclobutanes / Q000627:therapeutic use; D005234:Fatty Liver / Q000453:epidemiology*; D015390:Gastric Bypass; D006801:Humans; D006937:Hypercholesterolemia / Q000453:epidemiology*; D006973:Hypertension / Q000453:epidemiology*; D007333:Insulin Resistance; D007783:Lactones / Q000627:therapeutic use; D024821:Metabolic Syndrome / Q000453:epidemiology*; D009765:Obesity / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D000077403:Orlistat; D012307:Risk Factors
D019440:Anti-Obesity Agents; D001067:Appetite Depressants; D003503:Cyclobutanes; D007783:Lactones; D000077403:Orlistat; C058254:sibutramine